These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 5347491)

  • 1. Drug-induced behavioral states and their antagonists.
    Gershon S
    Psychopharmacol Bull; 1969 Apr; 5(2):22-3. PubMed ID: 5347491
    [No Abstract]   [Full Text] [Related]  

  • 2. Does oxybutynin alter plaques, amyloid beta peptides and behavior in a mouse model of Alzheimer's disease?
    Klausner AP; Sharma S; Fletcher S; Neff P; Yang SK; Son H; Tuttle JB; Steers WD
    J Urol; 2008 Mar; 179(3):1173-7. PubMed ID: 18206173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. General pharmacology of the new antimuscarinic compound vamicamide.
    Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K
    Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (S)-oxybutynin (Sepracor).
    Dmochowski RR
    Curr Opin Investig Drugs; 2002 Oct; 3(10):1508-11. PubMed ID: 12431028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between sarin and the cholinergic antagonist PMCG in fast and slow skeletal muscle of the cat.
    Brimblecombe RW; Everett SD
    J Physiol; 1969 Jul; 203(1):19P-20P. PubMed ID: 5821873
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclandelate: calcium modulation and clinical effects. Proceedings of a symposium. Helsinki, 14-15 November, 1986.
    Drugs; 1987; 33 Suppl 2():1-141. PubMed ID: 3622302
    [No Abstract]   [Full Text] [Related]  

  • 7. The selectivity of an anticholinergic drug on gastric secretion--a study of oxyphencyclimine hydrochloride.
    Herrmann RP; Piper DW
    Gut; 1970 Nov; 11(11):979. PubMed ID: 5531118
    [No Abstract]   [Full Text] [Related]  

  • 8. Behavioral and drug therapy for urinary incontinence.
    Goode PS
    Urology; 2004 Mar; 63(3 Suppl 1):58-64. PubMed ID: 15013654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits of cyclandelate in the treatment of disorders of ageing.
    Le Poncin-Lafitte M
    Br J Clin Pract Suppl; 1984; 34():58-61. PubMed ID: 6430325
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of cyclandelate on cholesterol synthesis.
    Middleton B; Middleton A; Miciak A; Edwards E; Whitten B; Bell GD; White DA
    Br J Clin Pract Suppl; 1984; 34():43-50. PubMed ID: 6430323
    [No Abstract]   [Full Text] [Related]  

  • 11. Modes and mechanisms of action of vasoactive drugs and especially of cyclandelate.
    Timmerman H
    Br J Clin Pract Suppl; 1984; 34():10-9. PubMed ID: 6430317
    [No Abstract]   [Full Text] [Related]  

  • 12. Medication update.
    Slagle M
    South Med J; 2002 Feb; 95(2):188-91. PubMed ID: 11846243
    [No Abstract]   [Full Text] [Related]  

  • 13. Choline acetylase inhibitors as potential antihallucinogens.
    Holan G
    Nature; 1965 Apr; 206(981):311. PubMed ID: 5836334
    [No Abstract]   [Full Text] [Related]  

  • 14. Adsorptive stripping voltammetric behavior and determination of anticholinergic agent oxybutynin chloride on a mercury electrode.
    Jain R; Radhapyari K; Jadon N
    J Colloid Interface Sci; 2007 Oct; 314(2):572-7. PubMed ID: 17618643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human platelet aggregation by cyclandelate.
    Van den Hoven WE; Hall DW
    Br J Clin Pract Suppl; 1984; 34():34-8. PubMed ID: 6430321
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclandelate and a number of its metabolites inhibit discocyte-echinocyte transformations of human erythrocytes.
    Van den Hoven WE; Hall DW; Burns JW
    Br J Clin Pract Suppl; 1984; 34():26-30. PubMed ID: 6430318
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of estradiol pretreatment on antimuscarinic action of oxybutynin in rat detrusor muscle.
    Yildiz O; Ozgok Y; Seyrek M; Un I; Kilciler M; Tuncer M
    Urology; 2005 Apr; 65(4):800-3. PubMed ID: 15833550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory action of cyclandelate and a number of its metabolites on cyclic AMP phosphodiesterase.
    Van den Hoven WE; Hall DW; Burns JW
    Br J Clin Pract Suppl; 1984; 34():20-5. PubMed ID: 6331483
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of aldose reductase from rat nervous tissue by metabolites of cyclandelate.
    Van den Hoven WE; Hall DW; Burns JW
    Br J Clin Pract Suppl; 1984; 34():31-3. PubMed ID: 6430320
    [No Abstract]   [Full Text] [Related]  

  • 20. Design, synthesis and activity of novel derivatives of oxybutynin and tolterodine.
    Kaur K; Aeron S; Bruhaspathy M; Shetty SJ; Gupta S; Hegde LH; Silamkoti AD; Mehta A; Chugh A; Gupta JB; Sarma PK; Kumar N
    Bioorg Med Chem Lett; 2005 Apr; 15(8):2093-6. PubMed ID: 15808475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.